- US-listed companies
- TELA Bio, Inc.
TELA Bio, Inc.TELA
Market cap
$65.63M
P/E ratio
Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | |
Revenue | 15 | 18 | 29 | 41 |
Cost of revenue (excluding amortization of intangible assets) | 6 | 7 | 10 | 14 |
Amortization of intangible assets | 0 | 0 | 0 | 1 |
Gross profit | 9 | 11 | 19 | 27 |
Sales and marketing | 18 | 22 | 29 | 43 |
General and administrative | 6 | 10 | 12 | 14 |
Research and development | 4 | 4 | 7 | 9 |
Total operating expenses | 28 | 37 | 48 | 66 |
Loss from operations | -19 | -25 | -29 | -39 |
Interest expense | 4 | 4 | 4 | 4 |
Loss on extinguishment of debt | - | - | - | -1 |
Other expense (income) | -3 | 0 | -0 | -0 |
Total other expense | - | -4 | -4 | -5 |
Net loss | -22 | -29 | -33 | -44 |
Net loss per common share, basic | - | - | -2.3 | -2.72 |
Earnings Per Share, Diluted | - | - | -2.3 | -2.72 |
Net loss | -22 | -29 | -33 | -44 |
Foreign currency translation adjustment | -0 | -0 | 0 | 0 |
Comprehensive loss | -22 | -29 | -33 | -44 |